HROW Q3 2023 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$34M+50.1% YoY

Gross Profit

$24M70.6% margin

Operating Income

$2M5.1% margin

Net Income

-$4M-12.8% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$21M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$286M

Total Liabilities

$211M

Stockholders' Equity

$76M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$23M	+50.1%
Gross Profit	$24M	$16M	+50.3%
Operating Income	$2M	-$94,000	+1955.3%
Net Income	-$4M	-$6M	+32.1%